A Missouri Senate panel has advanced legislation that could lower costs for some cancer patients.
Bills endorsed by the Senate insurance committee would require insurance companies to charge patients the same out-of-pocket costs for chemotherapy pills as they do for intravenous chemotherapy treatments.
Patients often currently are charged much more for oral chemotherapy. That’s because it is handled as a pharmacy benefit while intravenous treatments often trigger only a standard co-payment for an office visit.
Twenty-seven states and the District of Columbia already have enacted laws requiring equal coverage for oral and intravenous chemotherapy treatments.
The Missouri legislation now goes to the full Senate. A similar proposal is pending in a House committee.
The chemotherapy bills are SB66 and SB668.
Topics Missouri
Was this article valuable?
Here are more articles you may enjoy.
Allianz Unit to Cut as Many as 1,800 Jobs in Push to Adopt AI 
Travelers Builds Insurance-Specific LLM 
Tech and Finance Sectors Losing 28,000 Jobs Monthly Show AI Impact on Labor 
What 124 Future Business Leaders Really Think About AI and Work 
